Freenome, Inc. (FRNM) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Freenome, Inc. (FRNM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $120.6M, listed on NASDAQ, employing roughly 378 people, carrying a beta of 0.35 to the broader market. Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. Led by Aaron Elliott, public since 2026-07-21.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for FRNM as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →